James E. Liebmann, MD works in the field of Hematology. He attended University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a top medical college. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. He received 1 awards: "Meaningful Use Stage 1 Certification". James Liebmann is a published MD. He has 7 publications published. The most current publication "Phase II trial of 5-fluorouracil, leucovorin, interferon-alpha-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma." He accepts all Medicare patients.
NPI NUMBER | 1477556587 | |
NPPES Provider LastName | LIEBMANN | |
NPPES Provider FirstName | JAMES | |
NPPES Provider ZIPCode | 016550002 | |
NPPES Provider State | MA | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 655.0 | |
Distinct Opioid Count | 3.0 | |
Opioid Claim Count | 54.0 | |
Percent Opioid Claims | 8.24 |
National Provider Identifier [NPI] | 1477556587 |
Last Name Of The Provider | LIEBMANN |
First Name Of The Provider | JAMES |
View All |
Dr. Glen D. Raffel, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Mary E. Costanza, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Sulada Pukiat, MD | |
Dr. Olga Pozdnyakova, MD | |
Dr. Tony M. Samaha, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Richard J. Horner, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Venu G. Bathini, MD
This Doctor is OpenDoctor Recommended. |